Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 6:13 pm Purchase | 2024-09-30 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital LLC | 5,617,719 9.990% | 1,766,212 (+45.86%) | Filing History |
| 2024-11-14 5:12 pm Purchase | 2024-09-30 | 13G | Voyager Therapeutics, Inc. VYGR | ARMISTICE CAPITAL LLC | 5,200,000 9.540% | 964,000 (+22.76%) | Filing History |
| 2024-08-07 4:10 pm Purchase | 2024-07-31 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 5,459,941 10.000% | 2,827,262 (+107.39%) | Filing History |
| 2024-02-14 4:19 pm Sale | 2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Third Rock Ventures III L.P. | 186,423 0.400% | -5,279,211 (-96.59%) | Filing History |
| 2024-02-14 2:35 pm Purchase | 2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | ARMISTICE CAPITAL LLC | 4,236,000 9.630% | 840,000 (+24.73%) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | Voyager Therapeutics, Inc. VYGR | VANGUARD GROUP INC | 2,529,668 5.750% | 574,496 (+29.38%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 2,632,679 6.000% | 1,690,013 (+179.28%) | Filing History |
| 2023-02-24 06:15 am Purchase | 2023-02-23 | 13D | Voyager Therapeutics, Inc. VYGR | NEUROCRINE BIOSCIENCES INC NBIX | 8,575,316 19.900% | 4,395,588 (+105.16%) | Filing History |
| 2023-02-14 4:02 pm Sale | 2022-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Third Rock Ventures III L.P. | 5,465,634 14.200% | -3,953,663 (-41.97%) | Filing History |
| 2023-02-14 1:44 pm Purchase | 2022-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | ARMISTICE CAPITAL LLC | 3,396,000 8.800% | 3,396,000 (New Position) | Filing History |
| 2023-02-09 11:37 am Sale | 2022-12-30 | 13G | Voyager Therapeutics, Inc. VYGR | VANGUARD GROUP INC | 1,955,172 5.060% | -116,873 (-5.64%) | Filing History |
| 2023-01-13 4:33 pm Sale | 2023-01-11 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital LLC | 3,851,507 9.980% | -425,000 (-9.94%) | Filing History |
| 2022-04-26 12:58 pm Purchase | 2022-04-21 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital LLC | 4,276,507 11.100% | 719,000 (+20.21%) | Filing History |
| 2022-02-14 9:54 pm Sale | 2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | ARMISTICE CAPITAL LLC | 0 0.000% | -3,392,000 (Position Closed) | Filing History |
| 2022-02-14 4:01 pm Unchanged | 2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital LLC | 3,557,507 9.400% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:34 pm Sale | 2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | BB BIOTECH AG | 0 0.000% | -2,680,283 (Position Closed) | Filing History |
| 2022-02-10 08:42 am Sale | 2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | VANGUARD GROUP INC | 2,072,045 5.460% | -345,606 (-14.30%) | Filing History |
| 2021-10-22 4:46 pm Purchase | 2021-10-12 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital LLC | 3,557,507 9.400% | 3,557,507 (New Position) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 942,666 2.500% | -1,587,065 (-62.74%) | Filing History |
| 2021-02-16 5:11 pm Purchase | 2020-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | ARMISTICE CAPITAL LLC | 3,392,000 9.100% | 1,392,000 (+69.60%) | Filing History |